Louis C. Iorio

SCH 23390, a potential benzazepine antipsychotic with unique interactions on dopaminergic systems.

Louis C. Iorio, A Barnett, Frederick H. Leitz et al. · Journal of Pharmacology and Experimental Therapeutics · 1983 · 897 citations

Medicine, Pharmacology, Psychiatry +15

Characterization of the binding of 3H-SCH 23390, a selective D-1 receptor antagonist ligand, in rat striatum

William Billard, Vilma Ruperto, Gordon Crosby et al. · Life Sciences · 1984 · 567 citations · Full text

Medicine, Neuroscience, Pharmacology +16

6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.

G R Breese, G E Duncan, T. Celeste Napier et al. · Journal of Pharmacology and Experimental Therapeutics · 1987 · 212 citations · Full text

Medicine, Neuroscience, Pharmacology +17

Pharmacological profile of SCH39166: a dopamine D1 selective benzonaphthazepine with potential antipsychotic activity.

Richard E. Chipkin, Louis C. Iorio, Vicki L. Coffin et al. · Journal of Pharmacology and Experimental Therapeutics · 1988 · 183 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +16

Guanine nucleotide regulation of agonist interactions at [3H]SCH23390-labeled D1 dopamine receptors in rat striatum

Ellen J. Hess, George Battaglia, Andrew B. Norman et al. · European Journal of Pharmacology · 1986 · 115 citations

Life Sciences, Neuroscience, Pharmacology +16